Influx Healthtech Share Price Today

Influx Healthtech promoters hold 1.7 crore shares, report no encumbrance in FY26

Promoters of Influx Healthtech held 1,70,23,464 equity shares as of March 31, 2026, with no encumbrance reported during FY26. The disclosure, filed by Munir Abdul Ganee Chandniwala, complies with SEBI regulations. A detailed breakdown of shareholding among promoters and group members was provided in the filing.

Influx Healthtech reports FY26 revenue of INR146 crores

Influx Healthtech Limited reported a 41% year-on-year growth in H2 FY26 revenue, bringing full-year FY26 revenue to INR146 crores. PAT for the year stood at INR20.5 crores with an EBITDA of INR29.9 crores. The company is expanding its capacity with a new facility expected to be operational by August 2026 and has reallocated INR10 crores of IPO proceeds for this expansion. Management has provided guidance of 25-30% growth for FY27.

Influx Healthtech FY26 Net Profit Rises 54% to Rs 205.41 Crore

Influx Healthtech Limited reported a 54.3% YoY increase in FY26 net profit to Rs 2,054.13 lakh, with revenue growing 40% to Rs 14,683.36 lakh. The Nutraceuticals segment drove growth, contributing 90% of revenue, while the company expanded its operational capacity and received GMP compliance for the Tanzania market.

Influx Healthtech Passes Good Manufacturing Practices Inspection by Tanzania Bureau of Standards

Influx Healthtech has successfully passed a Good Manufacturing Practices inspection by the Tanzania Bureau of Standards, confirming that their manufacturing facility meets all required GMP standards. This certification validates the company's manufacturing processes, quality control systems, and regulatory compliance, enhancing their credibility in international markets and strengthening their position in the healthcare sector.

Influx Healthtech Boosts Production Capacity with New High-Speed Capsule Machine

Influx Healthtech has acquired a state-of-the-art high-speed capsule machine, increasing its production capacity from 23,000 to 145,000 capsules per hour, a 530% increase. The internally funded machine is expected to be operational within the current month. This upgrade aims to enhance output, market competitiveness, operational efficiency, and ability to meet growing demand in the healthcare technology sector.

Influx HealthTech Expands Operations with New Manufacturing Facility in Thane

Influx Healthtech, a pharmaceutical company, has announced the opening of a new manufacturing facility in Thane. The company plans to increase its production capacity by adding more tablet granulation lines in the future. This expansion is expected to enhance Influx Healthtech's production capabilities, technological advancement, and market competitiveness in the pharmaceutical sector.